QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625)
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase II Avastin Trial for Stage IIIB/IV NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of TAS-106 in Combo With Carboplatin
- Status
- COMPLETED
- Phase
- PHASE1
Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab and Carboplatin for Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3